Cytotoxic T lymphocytes specific for the simian immunodeficiency virus

Area of Science:

• Immunology
• Virology
• Vaccinology

Background:

• The simian immunodeficiency virus (SIV)-infected rhesus monkey serves as a non-human primate model for acquired immunodeficiency syndrome (AIDS).
• Understanding the role of virus-specific cytotoxic T-lymphocyte (CTL) responses in AIDS pathogenesis is critical for vaccine development.

Purpose of the Study:

• To investigate the role of SIV-specific CTL responses in disease pathogenesis using a rhesus monkey model.
• To assess the efficacy of a modified vaccinia Ankara (MVA) vector-based SIV vaccine in eliciting CTL responses.

Main Methods:

• Utilized major histocompatibility complex (MHC) class I/peptide tetramer technology to measure CTL responses.
• Employed an SIV-infected rhesus monkey model.
• Administered a live, recombinant SIV vaccine using the MVA vector.

Main Results:

• High numbers of tetramer-binding CD8+ T lymphocytes were found in peripheral blood, lymph nodes, and semen of SIV-infected monkeys.
• Early SIV clearance during primary infection correlated with the emergence of tetramer-binding CD8+ T lymphocytes.
• In vivo depletion of CD8+ lymphocytes abolished the monkeys' ability to control SIV replication.
• The MVA-based SIV vaccine elicited a high-frequency CTL response comparable to natural SIV infection.

Conclusions:

• Virus-specific CTL responses play a central role in containing SIV spread and are essential for controlling viral replication.
• An effective AIDS vaccine should aim to elicit a potent, virus-specific CTL response.
• Vaccine strategies employing MVA vectors show promise for developing an effective human immunodeficiency virus (HIV) vaccine.